Press Releases

The liquid hospital, a new patient care model based on e-health, represents a paradigm shift towards more personalized and precise medicine. The challenge in this context is cybersecurity in the interconnection between systems and medical devices inside and outside healthcare centers, as well as ensuring people's privacy

In silico research entails modeling, simulating, and visualizing biological and medical processes using computers. This context requires more collaborative research and data sharing for training mathematical models. Federated networks become a key element in ensuring the secure use of data

According to the IADB's cybersecurity guide for the healthcare sector, there is an average period of 329 days from a successful cyberattack to the institution’s awareness of its data breach

Cybersecurity incident response centers must possess advanced automation systems powered by artificial intelligence models. They need technology that can enhance the organization’s visibility when handling potential security incidents, along with response teams whose work is uniform and traceable

Analyzing speech can prove to be a valuable tool in predicting the onset of Alzheimer’s disease, according to research conducted using artificial intelligence tools in the TARTAGLIA project

Certain aspects of spontaneous language are linked to patients who exhibit an accumulation of beta-amyloid protein in the brain, a defining characteristic of individuals with this form of dementia

The technological development of MedP-Big Data project is complete. This project aims to improve personalized patient care, health promotion, prevention, and treatment using big data and artificial intelligence (AI)

The project will enable the healthcare services in the Canary Islands and Valencia to promote personalized and precision medicine

This is an example of a national project whose use cases could be applied to any current healthcare service

It is the second most common type of cancer that affects more than 1.2 million men worldwide and is the third leading cause of cancer death

With its technology, GMV facilitates the application of evidence-based personalized medicine, as well as the development of clinical guidelines for the benefit of the patient

Together with PIONEER and OPTIMA, the Evidence Hub of the European Association of Urology (EAU) and TARTAGLIA are some examples of GMV's contribution to the fight against prostate cancer

The direct benefit of ToxHub is that it allows preclinical and clinical databases to be brought together into an integrated data infrastructure, to help increase the efficiency of clinical trials, reduce research times, and achieve better results for toxicity studies

The platform is being used to increase the safety of pharmaceuticals, replacing some of the animal research by applying retrospective analysis technology to the evidence compiled by the pharmaceutical industry

The aim is to accelerate the uptake of digital technologies in areas such as personalized and precision medicine

The initiative is aligned with the company’s commitment to the United Nations Sustainable Development Goals (SDGs) and the European Union’s EU4Health program

 Healthcare system digitalization, system interoperability, the adaptation of processes and procedures to new needs, personalized and precision medicine, humanization or artificial intelligence in healthcare, and the use of big data to set up federated data networks are some of the topics that will be addressed as part of this forum

The purpose of this Spanish healthcare project is to improve personalized care for patients with chronic illnesses, cancer, and degenerative and rare diseases. It uses tools that assist with clinical decision-making to offer the public a more advanced and efficient healthcare system

Cuídat-e is one of the use cases of the Big Data Personalized Medicine project, which has a budget of €5,833,774, including €3,833,774 from the Canary Islands region (85% co‑funded by the Spanish Rare Disease Federation (FEDER), and €2,000,000 from the Valencian Community region (50% co‑funded by FEDER)

In addition, use of the Radiance^TM planning system allows estimation of the dose received in at‑risk organs, to help protect them from radiation side effects

These results are being published just as the Spanish Cancer Radiation Therapy Society (SEOR) prepares to commemorate the anniversary of the first documented radiotherapy cure

Almost 120,000 anonymized data records have already been identified for patients with hematologic malignancies. Research is now being focused on finding the most effective therapies that can cover the entire research spectrum for these forms of cancer, bringing new hope for those suffering from the less common types

GMV is the technological partner responsible for the secure platform that stores the data and makes it available for scientific analysis, with anonymization of the data and harmonization based on the common OMOP data model

The multinational firm is working on a solution to assist with the diagnosis of crew members while reducing the need for consultation with physicians on Earth

The project will enhance the use of ultrasound technology to capture clinically relevant medical images of the astronauts’ organs

GMV’s research campus is applying robotics and precision medicine to take on the battle against oligometastatic cancer

The DALEM project is an example of space technology transfer to dermatology and public-private collaboration between the Biomedical Research Foundation of Madrid's Hospital Universitario La Paz (FIBHULP) and GMV

This mobile application will make it possible to record the evolution of skin moles that the specialist can examine in a medical check-up

Self-scanning with a cell phone will make it possible to detect melanomas at an early stage, thus helping to reduce morbidity and mortality rates